Sentences with phrase «trial studies whose»

Not exact matches

In my experience, there actually are NDs whose care is rooted in science - and evidence - based medicine, and who base their recommendations on scientific studies and clinical trials.

On Monday, federal prosecutors in Mr. Silver's corruption trial turned to a relatively obscure staff member on the Assembly Ways and Means Committee whose title seemed as bland as the job he held — deputy budget director for budget studies — to open a window into the seemingly impenetrable world of state finances that Mr. Silver controlled.

In an effort to find out, Stephen P. Juraschek, M.D., Ph.D., research and clinical fellow in general internal medicine at the Johns Hopkins University School of Medicine, and his colleagues used data from the DASH (Dietary Approaches to Stop Hypertension) clinical trial, a widely popular and often - cited study whose results were first published in 1997.

Wyss - Coray, whose group did most of the mouse studies that inspired the clinical trial, now plans to conduct a second, larger trial using plasma from which many proteins and other molecules have been removed.

In 2011, Science's editors will be watching a smaller detector at the Large Hadron Collider called LHCb, which will study B mesons in great detail; new techniques that should lead to the discovery of many more genes contributing to adaptation; an ignited fusion burn at the National Ignition Facility; broadly neutralizing antibodies, which are capable of disabling a wide range of viral variants; the first plug - in hybrid electric cars whose batteries are charged from a wall socket go on the market; and the results of the first phase III trial of a malaria vaccine.

«By helping us understand that lower levels of RNF125 confer resistance to BRAF inhibitors, we have a new strategy to stratify patients for currently approved therapy versus participation for human clinical trials to investigate whether targeting JAK1 will be more effective in patients whose tumors exhibit reduced RNF125,» said Keith T. Flaherty, M.D., associate professor, Harvard Medical School, and director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, and co-author of the study.

The original pilot study for the trial involved women whose risk of breast cancer was four times the average.

«We would never have entered our child in this study if we'd know about the risks,» Shawn Pratt, whose daughter Dagen entered the SUPPORT trial at Duke University in 2007, told the hearing panel.

The 10 - year Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three continents.

«This is a very significant effect for a hypertension trial of any kind,» said Victor, whose own hypertension was diagnosed by a barber in Dallas during his first barbershop - based study in the 1990s.

We sponsor clinical trials for newly diagnosed neuroblastoma patients through the Children's Oncology Group (COG) and, through COG and the New Approaches to Neuroblastoma Therapy Consortium, Dana - Farber / Boston Children's offers the most Phase I clinical studies in New England for children whose disease has recurred.

Paris, France, April 3, 2018, 5.35 pm CET — GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA - PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced topline results from the REVERSE Phase III clinical trial evaluating the safety and efficacy of a single intravitreal injection of GS010 (rAAV2 / 2 - ND 4) in 37 subjects whose visual loss due to 11778 - ND4 Leber Hereditary Optic Neuropathy (LHON) commenced between 6 and 12 months prior to study treatment.

National Cancer Institute and ECOG - ACRIN announce the July 2015 opening of the NCI - MATCH / EAY131 trial, a multi-arm phase II precision medicine study that seeks to determine whether targeted therapies for people whose tumors have specific gene mutations will be effective regardless of cancer type.

While studies already showed that people whose diets were rich in foods high in vitamin C — typically 200 mg per day — have a lower risk of heart disease, certain cancers and other diseases, clinical trials testing isolated doses of synthetic C have mostly failed to find any protective benefit against disease.

Phase 1 trials would be small, nongenerablizable empirical studies whose dependent variable is not year - end test scores, but «next - day or next - week outcomes: measurable effects on student behavior, effort, or short - term learning.»

A paper reporting a «rigorous double blind» study — the VIGOR trial — was submitted to NEJM in 1998, got through peer review at one of the most up - tight journals in the world of medicine, and — by way of cherry - picking the data submitted (selecting out some study subjects whose adverse events histories which, if considered, would've significantly affected the safety profile for rofecoxib and revealed something that Merck really didn't want us prescribers to learn about their «blockbuster» product — was published to be touted by Merck's marketing weevils as solid proofs of Vioxx's tolerability, efficacy, and safety.

Can anyone imagine untenured Canadian legal academics undertaking a study whose question is: why do motion and trial judges write judgments?

The effects on internalizing disorders for the full sample, and on academic performance of children whose mothers had low psychological resources, are more likely to be valid since similar effects were found in the Denver trial (study 3, below).

We addressed some of the prior criticisms of EBT research by ensuring that (1) participants and study context were clinically representative, (2) there were no systematic differences in clinician competence across conditions (ie, all clinicians were randomly assigned), and (3) the sample would include the ethnic diversity that critics have found insufficient in the randomized controlled trial literature.17 - 20 Accordingly, we obtained samples from outpatient treatment programs that served the general public across a broad demographic and income range, we included only youths whose families sought treatment (ie, no recruiting or advertising), all treatment was provided by professional clinicians employed in the participating programs, and all treatment was provided in those programs (ie, not in university laboratory clinics).